VANLENT ANNE

Director at PENWEST PHARMACEUTICALS CO · on record since Jan 4, 2006
Director at INTEGRA LIFESCIENCES HOLDINGS CORP · on record since May 18, 2006
Exec. V.P., CFO and Treasurer at BARRIER THERAPEUTICS INC · on record since Apr 28, 2004
Director at TRANZYME INC · on record since Apr 21, 2011
Director at QLT INC/BC · on record since Dec 27, 2016
Director at Aegerion Pharmaceuticals, Inc. · on record since Apr 30, 2013
Director at NABI BIOPHARMACEUTICALS · on record since May 3, 2013
Director at Traws Pharma, Inc. · on record since Jul 29, 2013
Director at I STAT CORPORATION /DE/ · on record since Jan 30, 2004
Director at Trevi Therapeutics, Inc. · on record since Jun 4, 2026
Director at Atea Pharmaceuticals, Inc. · on record since May 13, 2016
Director at APPLIED GENETIC TECHNOLOGIES CORP · on record since Aug 18, 2016
Director at ObsEva SA · on record since Jan 3, 2023

Insider trading activity of VANLENT ANNE

Transactions on record: 152; since Sep 12, 2003

Open-market buys: 7; $301.2K

Open-market sells: 2; $257.2K

Companies traded: 12; last filing Jun 4, 2026

Figures computed from official regulatory filings — .

Companies where VANLENT ANNE has traded

Trevi Therapeutics, Inc.13 tx · $50K · Jun 4, 2026
APPLIED GENETIC TECHNOLOGIES CORP15 tx · Dec 1, 2022
NABI BIOPHARMACEUTICALS7 tx · $77K · Jun 14, 2019
14 tx · $19K · Dec 11, 2017
2 tx · $39.8K · May 22, 2017
2 tx · Dec 27, 2016
10 tx · $135.1K · Nov 30, 2016
4 tx · Jun 17, 2015
14 tx · $500.2K · May 21, 2012
48 tx · $225.5K · Sep 22, 2010
10 tx · $236.1K · Mar 17, 2008
13 tx · $1.1M · Jan 30, 2004

Track record of VANLENT ANNE

Statistical track record

Free

Open-market buys: 7

Last buy: May 9, 2019

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of VANLENT ANNE

Co-insiders of VANLENT ANNE

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Trevi Therapeutics, Inc.	Jun 4, 2026	AwardD (derivative)	35,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 13, 2025	AwardD (derivative)	45,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 14, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 30, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-10,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-16,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-10,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-10,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-12,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-14,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-8,000	—	—	SEC
Trevi Therapeutics, Inc.	Jul 1, 2022	AwardD (derivative)	20,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 23, 2022	AwardD (derivative)	20,000	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 2, 2021	AwardD (derivative)	14,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 17, 2021	AwardD (derivative)	20,000	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 18, 2020	AwardD (derivative)	12,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 15, 2020	AwardD (derivative)	14,210	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 6, 2019	AwardD (derivative)	10,000	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Jun 14, 2019	AwardD (derivative)	12,700	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Jun 14, 2019	AwardD (derivative)	9,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	May 13, 2019	Buy	5,000	10.00 USD	$50K	SEC
Trevi Therapeutics, Inc.	May 13, 2019	OtherD (derivative)	-107,977	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	May 13, 2019	Other	20,983	—	—	SEC
Trevi Therapeutics, Inc.	May 13, 2019	OtherD (derivative)	-47,807	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	May 8, 2019	AwardD (derivative)	23,684	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Trevi Therapeutics, Inc.	Jun 4, 2026	AwardD (derivative)	35,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 13, 2025	AwardD (derivative)	45,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 14, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 30, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-10,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-16,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-10,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-10,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-12,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-14,000	—	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 1, 2022	OtherD (derivative)	-8,000	—	—	SEC
Trevi Therapeutics, Inc.	Jul 1, 2022	AwardD (derivative)	20,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 23, 2022	AwardD (derivative)	20,000	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 2, 2021	AwardD (derivative)	14,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 17, 2021	AwardD (derivative)	20,000	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 18, 2020	AwardD (derivative)	12,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	Jun 15, 2020	AwardD (derivative)	14,210	0.00 USD	—	SEC
APPLIED GENETIC TECHNOLOGIES CORP	Dec 6, 2019	AwardD (derivative)	10,000	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Jun 14, 2019	AwardD (derivative)	12,700	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Jun 14, 2019	AwardD (derivative)	9,000	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	May 13, 2019	Buy	5,000	10.00 USD	$50K	SEC
Trevi Therapeutics, Inc.	May 13, 2019	OtherD (derivative)	-107,977	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	May 13, 2019	Other	20,983	—	—	SEC
Trevi Therapeutics, Inc.	May 13, 2019	OtherD (derivative)	-47,807	0.00 USD	—	SEC
Trevi Therapeutics, Inc.	May 8, 2019	AwardD (derivative)	23,684	0.00 USD	—	SEC